Park S, Kim TM, Han JY, Lee GW, et al. A Phase 3, Randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR or ALK mutated in non-small cell lung cancer (ATTLAS, KCSG-LU19-04). J Clin Oncol 2023 Oct 20:101200JCO2301891. doi: 10.1200/JCO.23.01891.
PMID: 37861993